| Cash Flow | 2026-04-30 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|
| Asset impairment charges | NaN | NaN | 302,284 |
| Net (loss) income | -721 | 19,571 | -270,377 |
| Depreciation and amortization | NaN | 103,444 | NaN |
| Loss (gain) on disposition of capital assets | NaN | -613 | NaN |
| Depreciation and amortization | -28,915 | NaN | 77,814 |
| Stock-based compensation | 2,402 | 923 | 2,762 |
| Deferred income tax | 918 | 7,905 | -26,440 |
| Charge for deferred loan costs and debt discount | NaN | 0 | NaN |
| Goodwill impairment charges | NaN | 302,284 | NaN |
| Gain on deal contingent foreign exchange forward currency contract | NaN | 0 | 0 |
| Noncash restructuring charges | NaN | 4,561 | NaN |
| Other, net | NaN | -7,114 | NaN |
| Other Noncash Income Expense | 5,403 | NaN | -9,203 |
| (increase) decrease in accounts receivable | 4,479 | 5,151 | 1,727 |
| Increase in inventory | 21,719 | -18,292 | -5,261 |
| Increase in other current assets | 6,200 | -3,575 | 7,228 |
| Decrease in accounts payable | -2,459 | 3,169 | 144 |
| Decrease in accrued liabilities | -10,411 | 68 | -9,725 |
| Change in income taxes | -12,005 | 11,129 | -21 |
| (decrease) increase in other long-term liabilities | NaN | 702 | -5,395 |
| Increase Decrease In Other Operating Capital Net | -689 | 644 | -88 |
| Cash (used for) provided by operating activities | -1,286 | 88,254 | 76,643 |
| Acquisitions, net of cash acquired | NaN | 0 | NaN |
| Capital expenditures | 22,322 | 21,646 | 40,996 |
| Proceeds from disposition of capital assets | 29 | 273 | 361 |
| Cash used for investing activities | -22,293 | -21,373 | -40,635 |
| Borrowings under credit facility | 119,000 | 20,000 | 170,000 |
| Repayments of credit facility borrowings | 99,500 | 51,250 | 213,750 |
| Debt issuance costs | NaN | 0 | NaN |
| Repayments of other long-term debt | 1,762 | 2,083 | 1,962 |
| Common stock dividends paid | 7,277 | 3,656 | 11,233 |
| Issuance of common stock | NaN | 0 | 214 |
| Proceeds from deal contingent foreign exchange forward currency contract | NaN | 0 | NaN |
| Payroll tax paid to settle shares forfeited upon vesting of stock | NaN | 0 | 1,400 |
| Purchase of treasury stock | 0 | 3,112 | 29,248 |
| Proceeds from (payment for) other financing activity | -696 | NaN | NaN |
| Cash provided by (used for) financing activities | 9,765 | -40,101 | -87,379 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,680 | -16,588 | 16,302 |
| Decrease in cash, cash equivalents and restricted cash | -12,134 | 10,192 | -35,069 |
| Cash, cash equivalents and restricted cash at beginning of period | 78,118 | 102,995 | NaN |
| Cash, cash equivalents and restricted cash at end of period | 65,984 | 78,118 | NaN |
Quanex Building Products CORP (NX)
Quanex Building Products CORP (NX)